K26: Individualized therapy for incurable breast cancer patients and elucidation of resistance mechanisms

HIPO Investigator:

Prof. Dr. Schneeweiss

Dr. Marc Zapatka


Supported by: HIPO

Entity: Breast Cancer

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.